Brings experience in R&D efforts, project management and team leadership in the medical-device industry.
Holds a B.Sc and M.Sc in biomedical engineering from the Technion, Israeli institute of technology.
Dr. Yair Feld
Founder and CMO
Interventional cardiologist, 15+ years experience. Founder of CorAssist, Nephera, Paragate Medical, ProArc, Cuspa and Genegrafts.
An experienced entrepreneur. For the past 30 years has been involved in the establishment and management of several medical devices. Chairman of the investment committee of NGT3 fund and incubator.
Chariman of the board
CEO & Managing Partner of NGT3 VC. Led the establishment and investment in more than 50 companies such as Prolor Biotech (sold to OPKO for $480M), Mazor Robotics (sold to Medtronic for $1.6B), ReWalk (NASDAQ: RWLK), Corindus (sold to Siemens Healthcare for $1.1B), and many others.
Dr. Amir Toren
Ph.D in Biochemistry and Microbiology from the department of Molecular Microbiology and Biotechnology, Tel Aviv University. Spanning a career of over 15 years, Amir brings extensive experience from the pharmaceutical industry of managing and developing multidisciplinary teams.
Manages the finances of NGT portfolio companies with strong leadership.
Involved in fund-raising processes, negotiations and complex transactions.
Dr. David Yakobi
MD, Medical Advisor
Scientific Advisory Board
Dr. Harindra Wijeysundera
Prof. Felix Mahfoud
Affiliate/Visiting Professor of the Harvard-MIT,Biomedical Engineering, Boston, MA
Prof. Jozef Bartunek
Prof. Giora Weisz